Oral lichen planus arising after BNT162b2 mRNA COVID-19 vaccine: report of 2 cases

The ongoing COVID-19 pandemic required a firm and prompt effort in the development of an effective vaccine. Reports of adverse reactions are increasing. Lichen planus, as well as its oral variant, is a condition that has previously been reported to be associated with vaccines. This is one of the fir...

Descripción completa

Detalles Bibliográficos
Autores principales: Raccampo, Luca, Sembronio, Salvatore, Tel, Alessandro, Cacitti, Veronica, Robiony, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995197/
https://www.ncbi.nlm.nih.gov/pubmed/35851250
http://dx.doi.org/10.1016/j.oooo.2022.04.003
_version_ 1784684262319980544
author Raccampo, Luca
Sembronio, Salvatore
Tel, Alessandro
Cacitti, Veronica
Robiony, Massimo
author_facet Raccampo, Luca
Sembronio, Salvatore
Tel, Alessandro
Cacitti, Veronica
Robiony, Massimo
author_sort Raccampo, Luca
collection PubMed
description The ongoing COVID-19 pandemic required a firm and prompt effort in the development of an effective vaccine. Reports of adverse reactions are increasing. Lichen planus, as well as its oral variant, is a condition that has previously been reported to be associated with vaccines. This is one of the first reports of oral lichen planus (OLP) arising after any COVID-19 vaccine. Here the authors present 2 cases of OLP that occurred after BNT162b2 mRNA COVID-19 vaccination (Comirnaty, Pfizer, New York, NY, USA; BioNTech, Mainz, Germany).
format Online
Article
Text
id pubmed-8995197
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-89951972022-04-11 Oral lichen planus arising after BNT162b2 mRNA COVID-19 vaccine: report of 2 cases Raccampo, Luca Sembronio, Salvatore Tel, Alessandro Cacitti, Veronica Robiony, Massimo Oral Surg Oral Med Oral Pathol Oral Radiol Case Report The ongoing COVID-19 pandemic required a firm and prompt effort in the development of an effective vaccine. Reports of adverse reactions are increasing. Lichen planus, as well as its oral variant, is a condition that has previously been reported to be associated with vaccines. This is one of the first reports of oral lichen planus (OLP) arising after any COVID-19 vaccine. Here the authors present 2 cases of OLP that occurred after BNT162b2 mRNA COVID-19 vaccination (Comirnaty, Pfizer, New York, NY, USA; BioNTech, Mainz, Germany). Elsevier Inc. 2022-09 2022-04-11 /pmc/articles/PMC8995197/ /pubmed/35851250 http://dx.doi.org/10.1016/j.oooo.2022.04.003 Text en © 2022 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Case Report
Raccampo, Luca
Sembronio, Salvatore
Tel, Alessandro
Cacitti, Veronica
Robiony, Massimo
Oral lichen planus arising after BNT162b2 mRNA COVID-19 vaccine: report of 2 cases
title Oral lichen planus arising after BNT162b2 mRNA COVID-19 vaccine: report of 2 cases
title_full Oral lichen planus arising after BNT162b2 mRNA COVID-19 vaccine: report of 2 cases
title_fullStr Oral lichen planus arising after BNT162b2 mRNA COVID-19 vaccine: report of 2 cases
title_full_unstemmed Oral lichen planus arising after BNT162b2 mRNA COVID-19 vaccine: report of 2 cases
title_short Oral lichen planus arising after BNT162b2 mRNA COVID-19 vaccine: report of 2 cases
title_sort oral lichen planus arising after bnt162b2 mrna covid-19 vaccine: report of 2 cases
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995197/
https://www.ncbi.nlm.nih.gov/pubmed/35851250
http://dx.doi.org/10.1016/j.oooo.2022.04.003
work_keys_str_mv AT raccampoluca orallichenplanusarisingafterbnt162b2mrnacovid19vaccinereportof2cases
AT sembroniosalvatore orallichenplanusarisingafterbnt162b2mrnacovid19vaccinereportof2cases
AT telalessandro orallichenplanusarisingafterbnt162b2mrnacovid19vaccinereportof2cases
AT cacittiveronica orallichenplanusarisingafterbnt162b2mrnacovid19vaccinereportof2cases
AT robionymassimo orallichenplanusarisingafterbnt162b2mrnacovid19vaccinereportof2cases

Ejemplares similares